Pulmonary Hypertension Trial, Recruiting NCT07311135 Sponsor: Golden Jubilee National Hospital Condition: Pulmonary Hypertension
Back to Pulmonary Hypertension

Pulmonary Hypertension Trial, Recruiting

NCT07311135
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 18 years or older.
  • People who have been diagnosed with pulmonary hypertension confirmed by a right heart catheterisation procedure, showing specific pressure and resistance measurements above set thresholds.
  • People who are able to complete a six-minute walk test (a test where a person walks as far as they can in six minutes).
  • People who are able to give written consent to take part.

Who may not be able to join:

  • People who have peripheral arterial disease (a condition affecting blood flow in the arteries of the limbs).
  • People who have tattoos or skin markings covering the back of the wrist.
  • People whose resting blood oxygen level is below 88%.
  • People with a serious ongoing medical condition that would prevent them from taking part in the study procedures, or whose life expectancy is less than 3 months.
  • People who have a bleeding disorder.
  • People who are currently taking blood-thinning medication (anticoagulants) — though there may be an exception for people taking these medications only because it was historically thought to improve long-term survival in pulmonary arterial hypertension. In that specific situation, the trial site may offer the option of pausing the medication for one week before the study visit and restarting it the following day, provided no bleeding complications occur (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Martin Johnson, BA, MBChB(Hons), MD, FRCP, Golden Jubilee National Hospital

Phone: (0044) 0141 951 5497

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Golden Jubilee National Hospital
Registry
ClinicalTrials.gov
Start date
17 December 2025
Est. completion
1 December 2026

Where this trial is recruiting

🇬🇧 United Kingdom

Primary endpoints

Agreement of oxygen saturations (SpO2) measured by the wrist-worn pulse oximeter when compared with arterial blood gas oxygen saturations (SaO2) at rest

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov